HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-Dirofilaria immitis IgE: seroepidemiology and seasonal variation in an exposed human population.

Abstract
The seroprevalence of seasonal variation of human anti-Dirofilaria immitis IgE levels were studied in an area where specific IgM and IgG had been previously investigated. An antibody capture ELISA assay was used to detect specific IgE. The IgE seroprevalence observed in the whole population was 12.6%. No specific IgE was detected in atopic individuals or in sera from people suffering other helminthiases. The distribution of the IgE anti-D. immitis seroprevalence by age groups did not show differences. Females had significantly higher levels than males. This isotype of immunoglobulin peaks in July, decreasing sharply in October, and persisting at a level similar to that of a non exposed population during the rest of the year. No specific IgE were detected in subjects with pulmonary alterations related to the parasite, suggesting a possible relationship between the clinico-radiological status and the type of immunoglobulin synthesized in subjects infected by D. immitis.
AuthorsE Espinoza, M Cordero, A Muro, F Lorente, F Simón
JournalTropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ) (Trop Med Parasitol) Vol. 44 Issue 3 Pg. 172-6 (Sep 1993) ISSN: 0177-2392 [Print] Germany
PMID8256091 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Helminth
  • Immunoglobulin E
Topics
  • Adult
  • Age Distribution
  • Aged
  • Analysis of Variance
  • Animals
  • Antibodies, Helminth (blood)
  • Dirofilaria immitis (immunology)
  • Dirofilariasis (epidemiology, immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin E (blood)
  • Lung Diseases, Parasitic (epidemiology, immunology)
  • Male
  • Middle Aged
  • Prevalence
  • Seasons
  • Sex Distribution
  • Spain (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: